Suppression of Amygdalar Endocannabinoid Signaling by Stress Contributes to Activation of the Hypothalamic–Pituitary–Adrenal Axis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Suppression of Amygdalar Endocannabinoid Signaling by Stress Contributes to Activation of the Hypothalamic–Pituitary–Adrenal Axis

Published:2009-08-26 Issue:13 Volume:34 Page:2733-2745
ISSN:0893-133X
Container-title:Neuropsychopharmacology
language:en
Short-container-title:Neuropsychopharmacol

Author:

Hill Matthew N,McLaughlin Ryan J,Morrish Anna C,Viau Victor,Floresco Stan B,Hillard Cecilia J,Gorzalka Boris B

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Pharmacology

Link

http://www.nature.com/articles/npp2009114.pdf

Reference67 articles.

1. Azad SC, Eder M, Marsicano G, Lutz B, Zieglgansberger W, Rammes G (2003). Activation of the cannabinoid receptor type 1 decreases glutamatergic and GABAergic synaptic transmission in the lateral amygdala of the mouse. Learn Mem 10: 116–128.

2. Azad SC, Monory K, Marsicano G, Cravatt BF, Lutz B, Zieglgansberger W et al (2004). Circuitry for associative plasticity in the amygdala involves endocannabinoid signaling. J Neurosci 24: 9953–9961.

3. Baran SE, Armstrong CE, Niren DC, Hanna JJ, Conrad CD (2009). Chronic stress and sex differences on the recall of fear conditioning and extinction. Neurobiol Learn Mem 91: 323–332.

4. Bhatnagar S, Vining C, Denski K (2004). Regulation of chronic stress-induced changes in hypothalamic-pituitary-adrenal activity by the basolateral amygdala. Ann NY Acad Sci 1032: 315–319.

5. Bingham B, Viau V (2008). Neonatal gonadectomy and adult testosterone replacement suggest an involvement of limbic arginine vasopressin and androgen receptors in the organization of the hypothalamic-pituitary-adrenal axis. Endocrinology 149: 3581–3591.

Cited by 251 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anandamide and disease. Role in stress, fear, and PTSD;Anandamide in Health and Disease;2025

2. Anandamide and mood disorders;Anandamide in Health and Disease;2025

3. Endocannabinoid signaling in stress, nausea, and vomiting;Neurogastroenterology & Motility;2024-09-02

4. Peripheral endocannabinoids in major depressive disorder and alcohol use disorder: a systematic review;BMC Psychiatry;2024-08-08

5. Endocannabinoid Hydrolase Inhibitors: Potential Novel Anxiolytic Drugs;Drug Design, Development and Therapy;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3